SCHEMBL24788071

SCHEMBL24788071

CNC(=O)OCc1ccc(NC(=O)C(C)NC(=O)CNC(=O)CCOCCOCCOCCOCCNC(=O)CCN2C(=O)C=CC2=O)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ OPRK1 P41145 2/20 0.33
▸ CA1 P00915 3/20 0.33
▸ CA2 P00918 3/20 0.33
▸ TPSAB1 Q15661 2/20 0.33
▸ CA12 O43570 2/20 0.33
▸ CA4 P22748 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ CA14 Q9ULX7 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ PLG P00747 1/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ SIRT1 Q96EB6 2/20 0.32
▸ SIRT2 Q8IXJ6 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ AKT1 P31749 1/20 0.31
▸ CAPN1 P07384 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18264893 0.92 OPRK1 (0.35) LMNAMEN1KMT2AOPRK1CA1
SCHEMBL23961617 0.89 CA12 (0.36) LMNAOPRK1CA1CA2CA12
SCHEMBL20402344 0.89 CA12 (0.36) LMNAOPRK1CA1CA2CA12
SCHEMBL18909059 0.86 CA12 (0.34) LMNAMEN1KMT2AOPRK1CA1
SCHEMBL17722949 0.86 CA12 (0.34) LMNAMEN1KMT2AOPRK1CA1
SCHEMBL17815411 0.86 CA12 (0.34) LMNAMEN1KMT2AOPRK1CA1
SCHEMBL19705582 0.86 CA12 (0.34) LMNAMEN1KMT2AOPRK1CA1
SCHEMBL23789199 0.86 CA12 (0.34) LMNAMEN1KMT2AOPRK1CA1
SCHEMBL24087858 0.86 OPRK1 (0.35) LMNAOPRK1CA1CA2CA12
SCHEMBL21008369 0.85 CA12 (0.33) LMNAMEN1KMT2AOPRK1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3870234-B1 ANTIBODY DRUG CONJUGATES COMPRISING ECTEINASCIDIN DERIVATIVES PHARMA MAR SA (ES) 2022-12-21 — — EP disclosed
Send feedback